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The compound 2-methyl-3-ethyl-4-phenyl-4-cyclohexene carboxylic acid (ORF 3858) is a potent post-coital antifertility agent in several mammalian species (Blye & Homm, 1967; Morris, Van Wagenen, McCann & Jacob, 1967) . The original report by Blye & Homm (1967) raised the question of whether ORF 3858 acts by direct action on the zygote or by oestrogenic alteration of tubal transport.
Because of their external development, amphibia such as the leopard frog, Rana pipiens, have had extensive application in the elucidation of the mechanisms of embryogenesis. The objective of this study was to determine whether ORF 3858 can directly affect Rana pipiens development, and whether such an effect is related to its oestrogenicity. Extrapolation of our findings to mammalian gestation must be conservative since the physiological environment in which embryonic development proceeds in mammals and amphibia is different. Interaction of the compound with fundamental embryonic processes can be more broadly interpreted since early development tends to be constant from species to species; the earlier the ontogenic stage, the greater the degree of constancy.
Males and gravid females were obtained commercially. Ovulation, artificial insemination, rearing and staging of embryos were as described by Rugh (1962) . Groups of twenty-five embryos were reared in 10% Ringer's solution containing ORF 3858, its 3 (ORF 5530) or 4 (ORF 5531) p-hydroxylated congeners (Grimes & Yard, 1967) , or other test compounds. Initial experiments, using ORF 3858 as a sodium salt, revealed that it blocks embryonic development. The degree of inhibition was found to depend on (1) the concentration of ORF 3858, (2) the duration of embryonic exposure to the compound and (3) the stage of development at which embryos are exposed. Development is blocked at cleavage, gastrulation, neurulation or hatching stages. As development proceeds, sensitivity to the compound increases. There are three manifestations of inhibition regardless of which stage is blocked; retardation of developmental rate followed by arrest and subsequent lysis. This finding is consistent with the contention of Blye & Homm (1967) that the compound acts directly as a zygolytic agent in rats. Such an hypothesis is supported by the preliminary evidence that development of cultured rabbit J. J. McCormack et al. zygotes in vitro is blocked by the compound (D. W. Hahn, personal communica¬ tion) .
A previous series of studies suggested that the antifertility effect of ORF 3858 in the rat results from the oestrogenicity of certain metabolites acting on the reproductive tract (Yard, Juhasz & Grimes, 1969; ). Accordingly, experiments comparing the relative effects of ORF 3858, its p-hydroxylated metabolite (ORF 5530) as a free acid and several 0-4 * ED50, the concentration in ßg/ral which causes 50% of the embryos to block before the hatching stage, was calculated from dose-response curves. t d/min per embryo . d/min per ml medium reference steroids were performed. In this form, both ORF 3858 and its metab¬ olite are effective, the metabolite somewhat less so. Strong oestrogens are the most potent developmental inhibitors, oestradiol-17)9 being the most active. Androgens have little or no activity. Progestagens, corticosteroids and choles¬ terol have no effect (Table 1 ) .
The differential sensitivity of embryos to inhibition by the above compounds might reflect either differential uptake of the compounds by embryonic cells or some chemical similarity of ORF 3858 to oestrogens. The relative rates of uptake of selected compounds by the frog embryo were measured. Fifty dejellied neurula stage embryos were placed in 10% Ringer's solution containing 4 µg/ml unlabelled compound and 3H-labelled compound as a marker. Em¬ bryos were periodically removed, washed and combusted for radioactivity determinations. The uptake rates of ORF 3858, and the potent oestrogens (oestrone, oestra¬ diol, and ethynyloestradiol) by embryos are greater than those of the weaker oestrogen, mestranol. The potent non-steroidal oestrogen, diethylstilboestrol, is not rapidly incorporated. Non-oestrogenic compounds such as progesterone, dihydrotestosterone and testosterone are taken up as rapidly as are potent oestrogens. Our data showed no correlation between the rate of embryonic uptake of the compounds and their ability to block development (Table 1) . The effect of ORF 3858 on development may, therefore, stem from some struct¬ ural similarity to oestrogenic compounds. Steroid hormones, especially oestrogens, have been shown to inhibit develop¬ ment in a variety of species (Meyer, Kosmo & McShan, 1947; Jolley, Martin, Bamberger & Steams, 1962; Daniel & Cowan, 1966) . Furthermore, the binding of oestrogens to a cytoplasmic 'receptor' protein and subsequent enhancement of RNA synthesis are considered early critical events in the response of cells in oestrogen target tissues in mammals (Hahn, McGuire, Greenslade & Turner, 1971) . We asked whether ORF 3858 interacts at these known endpoints of oestrogenicity in the frog embryo.
In the receptor studies, approximately 400 embryos (hatching stage), ten rabbit uteri or sixty rat uteri were homogenized in 0-1 M-tris-HCl (pH 7-5), containing 1-0 mM-EDTA and 0-25 M-sucrose. Cytosol (275,000 g supernatant) fractions were assayed for the presence of oestrogen-binding components according to the methods described in McGuire, Bariso, Fuller, McElrath & Delahunte (1972) . Tritiated oestradiol-17/? was substantially bound in rabbit uterine cytosol, whereas little bound to that from frog embryos. Although unlabelled oestrogens (ethynyloestradiol and ORF 5530) inhibited [3H]oestradiol-17/? binding in rabbit uterine cytosol, a similar effect was not noted for frog embryo cytosol. When rat uterine cytosol was incubated with [3H]oestradiol-17)8 and analysed by sucrose density centrifugation, a peak of radioactivity was found which could be depressed by unlabelled oestrogens. No such band of radioactivity was found in frog embryo cytosol. Apparently, uptake of oestradiol and the oestrogenic metabolites of ORF 3858 by frog embryonic cells does not involve specific high affinity oestrogen-binding components.
In the nucleic acid synthesis experiments, twenty de-jellied embryos (neurula stage) were incubated for 4 hr at 18°C in 2-5 [3H]guanine sulphate Ci/ml and either ORF 3858 (25µg/ml) or oestradiol-17ß (10µg/ml). Nucleic acid synthesis was measured according to Hahn et al. (1971) . Control study related to the report that when metabolic hydroxylation of ORF 3858 was blocked, its antifertility activity in rats was markedly reduced in mammals (Yard et al., 1969) . Our finding that ORF 3858 blocks develop¬ ment indicates that either the embryo is competent to convert the compound to the hydroxylated form, or that, at the embryonic level, ORF 3858 acts directly. We tested, therefore, the ability of frog embryos to metabolize ORF 3858. Approximately 300 embryos or 2-5 g adult frog liver were homogenized in 10 ml phosphate buffer (0-01 m, pH = 7-4). One-ml aliquots of 8500 g supernatant fractions were incubated at 20-5°C with 400 µg [3H]ORF 3858 according to the method of Müller & Miller (1953) . Samples were acidified to pH 2-0 and extracted with ethyl acetate. Dried residues were dissolved in 1:1 (v/v) methanol : ethyl acetate, and ORF 3858, 5530 and 5531 were sep¬ arated (a) by thin-layer chromatography using silica GF plates and benzene: acetic acid and (b) by gas-liquid chromatography. While adult frog liver preparations converted 36-9% of the ORF 3858 to ORF 5531 and 13-2% to ORF 5530 in 3 hr, no evidence of metabolism by embryos at any stage of development or by the 5-day free-swimming tadpoles was obtained.
In conclusion, ORF 3858 and other potent oestrogens selectively block development of Rana pipiens embryos. The frog embryo apparently does not possess oestrogen receptors and neither ORF 3858 nor oestrogens modify embryonic nucleic acid synthesis. The compound appears to be unaltered by embryonic metabolism. In this system, ORF 3858 apparently acts directly as a zygolytic agent through mechanisms unlike those by which oestrogens function at the target level in mammals.
